Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Standard
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. / Kocheise, Lorenz; Piseddu, Ignazio; Vonderlin, Joscha; Tjwa, Eric T; Buescher, Gustav; Meunier, Lucy; Goeggelmann, Pia; Fianchi, Francesca; Dumortier, Jérôme; Barciela, Mar Riveiro; Gevers, Tom J G; Beretta-Piccoli, Benedetta Terziroli; Londoño, Maria-Carlota; Frankova, Sona; Roesner, Thomas; Joerg, Vincent; Schmidt, Constantin; Glaser, Fabian; Sutter, Jan P; Fründt, Thorben W; Lohse, Ansgar W; Huber, Samuel; von Felden, Johann; Sebode, Marcial; Schulze, Kornelius.
In: FRONT IMMUNOL, Vol. 15, 2024, p. 1369747.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
AU - Kocheise, Lorenz
AU - Piseddu, Ignazio
AU - Vonderlin, Joscha
AU - Tjwa, Eric T
AU - Buescher, Gustav
AU - Meunier, Lucy
AU - Goeggelmann, Pia
AU - Fianchi, Francesca
AU - Dumortier, Jérôme
AU - Barciela, Mar Riveiro
AU - Gevers, Tom J G
AU - Beretta-Piccoli, Benedetta Terziroli
AU - Londoño, Maria-Carlota
AU - Frankova, Sona
AU - Roesner, Thomas
AU - Joerg, Vincent
AU - Schmidt, Constantin
AU - Glaser, Fabian
AU - Sutter, Jan P
AU - Fründt, Thorben W
AU - Lohse, Ansgar W
AU - Huber, Samuel
AU - von Felden, Johann
AU - Sebode, Marcial
AU - Schulze, Kornelius
N1 - Copyright © 2024 Kocheise, Piseddu, Vonderlin, Tjwa, Buescher, Meunier, Goeggelmann, Fianchi, Dumortier, Barciela, Gevers, Beretta-Piccoli, Londoño, Frankova, Roesner, Joerg, Schmidt, Glaser, Sutter, Fründt, Lohse, Huber, von Felden, Sebode and Schulze.
PY - 2024
Y1 - 2024
N2 - [This corrects the article DOI: 10.3389/fimmu.2023.1326078.].
AB - [This corrects the article DOI: 10.3389/fimmu.2023.1326078.].
U2 - 10.3389/fimmu.2024.1369747
DO - 10.3389/fimmu.2024.1369747
M3 - Other (editorial matter etc.)
C2 - 38327519
VL - 15
SP - 1369747
JO - FRONT IMMUNOL
JF - FRONT IMMUNOL
SN - 1664-3224
ER -